Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 86

Sort by

Sort Order Select

Journal Articles

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Blood (2019) 134 (Supplement_1): 1066.

https://doi.org/10.1182/blood-2019-131064

Published: 2019

Journal Articles

Daratumumab Monotherapy in Previously Untreated High-Risk Patients with Stage 3B Light Chain (AL) Amyloidosis: A Phase II Multicenter Study By European Myeloma Network (EMN)

Eftathios Kastritis, Monique C. Minnema, Meletios A. Dimopoulos, MD, Giampaolo Merlini, MD, Pieter Sonneveld, Giovanni Palladini, MD PhD

Blood (2019) 134 (Supplement_1): 1868.

https://doi.org/10.1182/blood-2019-126524

Published: 2019

Journal Articles

Cardiac Injury and Microvascular Ischemia in Sickle Cell Disease

Kiranveer Kaur, Ying Huang, MS, MA, Subha Raman, MD MS, Eric H. Kraut, MD, Payal Desai, MD

Blood (2019) 134 (Supplement_1): 2286.

https://doi.org/10.1182/blood-2019-125445

Published: 2019

Journal Articles

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Phani Borra, MD, Cory Edward Mellon, MD

Blood (2019) 134 (Supplement_1): 4905.

https://doi.org/10.1182/blood-2019-128537

Published: 2019

Journal Articles

Amyloidosis and Plasma Cell Dyscrasias: A Single Institution Experience

Poornima Ramadas, MBBS, Ajay Tambe, MBBS, Mijung Lee, MD

Blood (2019) 134 (Supplement_1): 5463.

https://doi.org/10.1182/blood-2019-131577

Published: 2019

Journal Articles

Clinical Efficacy of L-Annamycin, a Liposomal Formulated Non-Cross-Resistant and Non-Cardiotoxic Anthracycline in Relapsed/Refractory AML Patients

Lidia Gil, MD PhD, Robert C. Shepard, MD, Sandra L Silberman, MD PhD, Ewa Maria Zak, MSc, Waldemar Priebe, PhD

Blood (2019) 134 (Supplement_1): 5147.

https://doi.org/10.1182/blood-2019-129268

Published: 2019

Journal Articles

A Functional Analysis of SNP on Anthracycline-Induced Cardiotoxicity in a Uniform Genetic Background Using CRISPR/Cas9 Mediated Single-Base-Edited iPSCs

Takayuki Nakamura, MD, Shinichi Mizuno, MD PhD, Hidetoshi Ozawa, Yoshitaka Yamasaki, MD, Shuki Oya, MD, Satoshi Morishige, MD, Kazutoshi Aoyama, MD PhD, Maki Ymaguchi, MD PhD, Ritsuko Seki, PhD, Fumihiko Mouri, MD PhD, Koichi Osaki, MD, Koji Nagafuji, MD PhD

Blood (2019) 134 (Supplement_1): 5748.

https://doi.org/10.1182/blood-2019-123932

Published: 2019

Journal Articles

Plasma Levels of Histone-DNA Complex and Cell-Free DNA Predict Mortality in Patients with Immune Thrombotic Thrombocytopenic Purpura

Jingrui (Jean) Sui, MD, Konstantine Halkidis, MD PhD, Nicole K. Kocher, Lance A. Williams, III, MD, Radhika Gangaraju, MD, Bryan K. Guillory, MD, Marisa B. Marques, MD, Wenjing Cao, MD,PhD, X. Long Zheng, MD, PhD

Blood (2019) 134 (Supplement_1): 1070.

https://doi.org/10.1182/blood-2019-131585

Published: 2019

Journal Articles

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Adolfo E Diaz, MD, Matthew James Butler, MD, Anand Karnad, MD, Ricardo Aguiar, MD PhD

Blood (2019) 134 (Supplement_1): 1592.

https://doi.org/10.1182/blood-2019-124382

Published: 2019

Journal Articles

Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry

Stephen Parkin, MD BSc, Michael A. Seidman, MD FRCPC, Margot Davis, MD FRCPC, Kevin Song, MD

Blood (2018) 132 (Supplement 1): 3126.

https://doi.org/10.1182/blood-2018-99-115317

Published: 2018

Journal Articles

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Hang Quach, MDFRACP,FRCPA,MBBS, Khue Minh Nguyen, Matthew Ku, MBBS, FRACP, FRCPA, Ali Bazargan, MBBS FRACP FRCPA, Robin J Filshie, PhDFRACP,FRCPA, Constantine S. Tam, MBBS, MD FRACP, FRCPA, Lisa Catherine Demosthenous, MPH, BSN, David Prior, MBBS FRACP PhD

Blood (2018) 132 (Supplement 1): 1956.

https://doi.org/10.1182/blood-2018-99-113802

Published: 2018

Journal Articles

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Todd Clover, MD MS, Ronald S. Go, MD, Ana G. Antun, MD, Spero R Cataland, MD, Shruti Chaturvedi, MBBS,MS, Elizabeth Davis, Andrew Johnson, MD, Ming Yeong Lim, MBBChir, Meera Sridharan, MD, Keith McCrae, MD, J. Evan Sadler, MD PhD, Marshall A. Mazepa, MD, Lisa Baumann-Kreuziger, MS MD

Blood (2017) 130 (Supplement 1): 3624.

https://doi.org/10.1182/blood.V130.Suppl_1.3624.3624

Published: 2017

Journal Articles

Sanguinate: A Novel Blood Substitute Product

Trisha Plastini, DO, Patricia Locantore-Ford, MD, Heather Bergmann, MPH, BSN, RN

Blood (2017) 130 (Supplement 1): 1120.

https://doi.org/10.1182/blood.V130.Suppl_1.1120.1120

Published: 2017

Journal Articles

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

Blood (2017) 130 (Supplement 1): 3901.

https://doi.org/10.1182/blood.V130.Suppl_1.3901.3901

Published: 2017

Journal Articles

Identifying Clinical Gaps in the Diagnosis, Monitoring, and Management of Immunoglobulin Light Chain (AL) Amyloidosis Among Hematologist/Oncologists

Emily S Van Laar, Morie A. Gertz, MD

Blood (2017) 130 (Supplement 1): 4672.

https://doi.org/10.1182/blood.V130.Suppl_1.4672.4672

Published: 2017

Journal Articles

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Shahla Bari, MD, Marina Rabinovich, PharmD, BCPS, Marjorie Curry, PharmD, BCOP, Sanjay Raj Jain, MD PhD, Lorraine Cafuir, MD

Blood (2017) 130 (Supplement 1): 4926.

https://doi.org/10.1182/blood.V130.Suppl_1.4926.4926

Published: 2017

Journal Articles

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Bhavisha Patel, MD, Barac Ana, MD, Kelly W. Fitzpatrick, MD, Aarthi Shenoy, MD

Blood (2017) 130 (Supplement 1): 5032.

https://doi.org/10.1182/blood.V130.Suppl_1.5032.5032

Published: 2017

Journal Articles

Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

Blood (2017) 130 (Supplement 1): 1855.

https://doi.org/10.1182/blood.V130.Suppl_1.1855.1855

Published: 2017

Journal Articles

HOVON 104; Results of First 25 Patients from a Multicenter, Multinational, Prospective Phase II Study of Bortezomib Based Induction Treatment Followed By Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Al Amyloidosis

Monique Minnema, Kazem Nasserinejad, MA, Bouke Hazenberg, MD PhD, Ute Hegenbart, Lucien Noens, MD PhD, Paula F. Ypma, MD, Sonja Zweegman, MD PhD, Lidwine Winnifred Tick, MD PhD, Annemiek Broijl, MD PhD, Harry R. Koene, MD PhD, Gerard M.J. Bos, MD PhD, Pieter Sonneveld, MD PhD, Stefan O. Schoenland, MD

Blood (2016) 128 (22): 4628.

https://doi.org/10.1182/blood.V128.22.4628.4628

Published: 2016

Journal Articles

Bendamustine, Carfilzomib, and Melphalan (BCM) Conditioning Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Feasibility Study

A. Samer Al-Homsi, MD, Marlee Muilenburg, BSN, Kelli Cole, MSN, Muneer H. Abidi, MD, Stephanie F. Williams, MD

Blood (2016) 128 (22): 4635.

https://doi.org/10.1182/blood.V128.22.4635.4635

Published: 2016

NARROW

African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic Purpura

Daratumumab Monotherapy in Previously Untreated High-Risk Patients with Stage 3B Light Chain (AL) Amyloidosis: A Phase II Multicenter Study By European Myeloma Network (EMN)

Cardiac Injury and Microvascular Ischemia in Sickle Cell Disease

A Case of Mistaken Identity: TTP-like State Due to Heroin Overdose

Amyloidosis and Plasma Cell Dyscrasias: A Single Institution Experience

Clinical Efficacy of L-Annamycin, a Liposomal Formulated Non-Cross-Resistant and Non-Cardiotoxic Anthracycline in Relapsed/Refractory AML Patients

A Functional Analysis of SNP on Anthracycline-Induced Cardiotoxicity in a Uniform Genetic Background Using CRISPR/Cas9 Mediated Single-Base-Edited iPSCs

Plasma Levels of Histone-DNA Complex and Cell-Free DNA Predict Mortality in Patients with Immune Thrombotic Thrombocytopenic Purpura

Combination of Phosphodiesterase 4 (PDE4) Inhibitor Roflumilast and R-CHOP As First-Line Therapy for High-Risk Diffuse Large B Cell Lymphoma Patients

Clinical Characteristics and Outcome of Patients with Wild-Type Transthyretin and AL Cardiac Amyloidosis Confirmed By Mass Spectrometry

Characterization of Cardiovascular Adverse Events and B-Type Natriuretic Peptide Levels in Patients with Multiple Myeloma Who Are Treated with Carfilzomib

Factors Associated with Mortality in Immune-Mediated Thrombotic Thrombocytopenic Purpura: Results from the United States Thrombotic Microangiopathy TTP Registry

Sanguinate: A Novel Blood Substitute Product

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

Identifying Clinical Gaps in the Diagnosis, Monitoring, and Management of Immunoglobulin Light Chain (AL) Amyloidosis Among Hematologist/Oncologists

Use of Hemoglobin Based Oxygen Carrier HBOC-021 (Hemopure) As a Bridge during Emergencies in Patients Unable to Receive Blood Products: Experience at a Tertiary Care Center

Ten-Day Decitabine Treatment in AML Associated with Reversible Non-Ischemic Cardiomyopathy

Prospective Study of Cardiac Events during Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma

HOVON 104; Results of First 25 Patients from a Multicenter, Multinational, Prospective Phase II Study of Bortezomib Based Induction Treatment Followed By Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Al Amyloidosis

Bendamustine, Carfilzomib, and Melphalan (BCM) Conditioning Prior to Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Feasibility Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only